Adverum Biotechnologies (ADVM) Tops Q4 EPS by 11c

Adverum Biotechnologies (NASDAQ: ADVM) reported Q4 EPS of ($0.23), $0.11 better than the analyst estimate of ($0.34).

For earnings history and earnings-related data on Adverum Biotechnologies (ADVM) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• The Lovesac Company (LOVE) Tops Q1 EPS by 29c
• United Community Banks sells equipment finance unit for $1.9 billion